1/11/2018Recent Executive Moves

1/11/2018Ten Contemporary Chinese Biopharma Industry Predictions in 2018

1/11/2018Fosun's Wanbang Pharma and Bial Enter Exclusive Licensing Agreement fo...

1/10/2018Data Snapshot: Chinese Hospital Consumption of Cholesterol-Reduction D...

1/10/2018Indigenously-developed Class 1 New Chemical Drugs Approved in China 20...

1/10/2018CPIIC: Chinese Urban Hospital Drug Market Expected to be Flat in 2017

1/10/2018Numerous Provinces Expand Disease Group-Based BMI Payment Scheme at th...

1/9/2018Sinobioway Sunterra Biotech to Initiate Trial of Two AB-CAR-T Candidat...

1/9/2018BeiGene and Boehringer Enter Supply Agreement for Anti-PD-1 Antibody T...

1/9/2018CFDA Issues Guide for Development of Supplemental Drug Testing Methods

1/8/2018TG Therapeutics and Hengrui Medicine Announce Global License Agreement...

1/8/2018Ascentage Announces IND Acceptance by CFDA for Clinical Study of Novel...

1/8/2018Merus and Simcere Announce Strategic Collaboration on Multiple Bispeci...

1/8/2018NHFPC Outlines Ten Areas of Reform Action in the New Year

1/8/2018MNCs Reorganize and Launch New Products in China

1/8/2018CFDA Approves 29 More Medical Institutions as Designated Clinical Rese...

1/8/2018CFDA Solicits Comments on Drug Data Management Guidelines

1/5/2018CFDA Solicits Comments on the Draft Rules for Drug Inspection

1/5/2018Biostage Raises $4.2M from Chinese Investor Group

1/5/2018Cantargia Granted Chinese Patent for Antibody Treatment against IL1RAP...

1/5/2018China-based KPB Biosciences to Move HQs to Philadelphia Area

1/4/2018Recent Executive Moves

1/4/2018Amendments Of Anti-Unfair Competition Law

1/4/2018WIPO: China Leads Innovation by Quantity

1/4/2018Roche's NDA for Breast Cancer Drug Perjeta Accepted in China

1/4/2018Novartis Lost Gleevec Infringement Lawsuit in China against Jiangsu Ha...

1/4/2018CFDA Approves New Once-Weekly Bydureon to Improve Glycemic Control in ...

1/4/2018Angiochem and Xinogen Enter License Agreement for Breast Cancer Drug C...

1/3/2018CFDA Issues Guidelines for Clinical Trials of Overactive Bladder Drugs

1/3/2018ASLAN Pharma Acquires Global Rights for Varlitinib from Array BioPharm...

Page:337/774 Total number of articles:23208: [First][<<] [335] [336] [337] [338] [339] [>>] [End]